Registrars: | Equiniti |
Brands: | Losec, Prilosec, Nexium, Crestor |
Senior Independent Non-Executive Director: | Philip A J Broadley |
CEO and Executive director: | Pascal Soriot |
CFO & Executive Director: | Aradhana Sarin |
Chairman: | Michel Demare |
Independent Non-Executive Director: | Tony Mok |
Independent Non-Executive Director: | Nazneen Rahman |
Independent Non-Executive Director: | Sheri McCoy |
Independent Non-Executive Director: | Euan Ashley |
Independent Non-Executive Director: | Deborah DiSanzo |
Independent Non-Executive Director: | Diana Layfield |
Non-Executive Dir: | Marcus Wallenberg, Andreas Rummelt, Anna Manz |
Address: | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge,United Kingdom, CB2 0AA |
Phone: | +44 (0)20 3749 5000 |
Fax: | +44 (0)20 7604 8151 |
Website: | http://www.astrazeneca.com |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE 100, FTSE 350, FTSE All-Share |
Overseas Listings: | BATSLON:AZNL |
ISIN: | GB0009895292 |
Currency | UK Pounds |
Share Price | 11,260.00p |
Change Today | 10.00p |
% Change | 0.09 % |
52 Week High | 12,294.00p |
52 Week Low | 9,501.00p |
Volume | 1,437,336 |
Shares Issued | 1,550.22m |
Market Cap | £174,555m |
RiskGrade | 123 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 8 |
Buy | 13 |
Neutral | 6 |
Sell | 0 |
Strong Sell | 1 |
Total | 28 |
Latest | Previous | |
---|---|---|
2nd Interim | 1st Interim | |
Ex-Div | 22-Feb-24 | 10-Aug-23 |
Paid | 25-Mar-24 | 11-Sep-23 |
Amount | 197.00¢ | 93.00¢ |
Time | Volume / Share Price |
15:03 | 12 @ 11,260.00p |
15:03 | 3 @ 11,260.00p |
15:03 | 56 @ 11,260.00p |
15:03 | 47 @ 11,260.00p |
15:03 | 10 @ 11,260.00p |
You are here: research